The Enterprise Value as of December 2024 (TTM) for Karuna Therapeutics, Inc. (KRTX) is 12.43B

According to Karuna Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.43B. This represents a change of 57.12% compared to the average of 7.91B of the last 4 quarters.

Karuna Therapeutics, Inc. (KRTX) Historical Enterprise Value (quarterly & annually)

How has KRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Karuna Therapeutics, Inc. over the last ten years is 3.53B. The current 12.43B Enterprise Value has changed 35.07% with respect to the historical average. Over the past ten years (40 quarters), KRTX's Enterprise Value was at its highest in in the December 2023 quarter at 11.79B. The Enterprise Value was at its lowest in in the June 2019 quarter at -8083636.00.

Karuna Therapeutics, Inc. (KRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Karuna Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Karuna Therapeutics, Inc. (KRTX) Average Enterprise Value

How has KRTX Enterprise Value performed in the past?

The current Enterprise Value of Karuna Therapeutics, Inc. (KRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Karuna Therapeutics, Inc. (KRTX) Enterprise Value vs. Peers

How is KRTX’s Enterprise Value compared to its peers?

Karuna Therapeutics, Inc.’s Enterprise Value is greater than IVERIC bio, Inc. (5.13B), greater than Blueprint Medicines Corporation (6.12B), greater than Amylyx Pharmaceuticals, Inc. (209.72M), greater than Day One Biopharmaceuticals, Inc. (859.59M), greater than X4 Pharmaceuticals, Inc. (79.21M), greater than Inozyme Pharma, Inc. (215.58M), greater than Acumen Pharmaceuticals, Inc. (103.15M), greater than Mereo BioPharma Group plc (445.16M), greater than Terns Pharmaceuticals, Inc. (234.86M), greater than Mirati Therapeutics, Inc. (3.91B), greater than Apellis Pharmaceuticals, Inc. (4.20B), greater than Cytokinetics, Incorporated (6.52B), greater than DICE Therapeutics, Inc. (1.82B), greater than Edgewise Therapeutics, Inc. (2.80B), greater than Dyne Therapeutics, Inc. (1.93B),

Build a custom stock screener for Karuna Therapeutics, Inc. (KRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Karuna Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Karuna Therapeutics, Inc. (KRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Karuna Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.